Standard-Dose Quadrivalent Influenza Vaccine
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Standard-Dose Quadrivalent Influenza Vaccine, covering 2022-08-23 to 2025-09-12. Get the full timeline:
Most recent: Clinical Trial Update: A Pragmatic Randomized Trial to Evaluate the Effectiveness of High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in Older Adults [Phase 4]